Drugs / High-Dose TIV
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03022435 | Oct 2012 → Jan 2013 | influenza | Stanford University | Completed | No outcome recorded |
| Phase 4 | NCT03022422 | Sep → Dec 2011 | influenza | Stanford University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High-Dose TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03022435 ↗ |
| Known as | High-Dose Influenza Virus Vaccine | “High-Dose Influenza Virus Vaccine supplied in a prefilled, single-dose syringe” NCT03022435 ↗ |
| Modality | Vaccine | “High-Dose Influenza Virus Vaccine” NCT03022422 ↗ |
| Route | Intramuscular | “High-Dose Influenza Virus Vaccine supplied in a prefilled, single-dose syringe for intramuscular injection” NCT03022422 ↗ |